LXRX Lexicon Pharmaceuticals
- 1.700
- 0.0000.00%
- 1.700
- 0.0000.00%
Lexicon Pharmaceuticals News
Piper Sandler Reaffirms Their Buy Rating on Lexicon Pharmaceuticals (LXRX)
Needham: Reiterates that Lexicon Pharmaceuticals (LXRX.US) holds the rating.
Lexicon Pharmaceuticals Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Cigna (CI), Lexicon Pharmaceuticals (LXRX)
Optimistic Buy Rating for Lexicon Pharmaceuticals Amid Strong Inpefa Sales Outlook and Efficient Financial Management
Needham Keeps Their Hold Rating on Lexicon Pharmaceuticals (LXRX)
Lexicon Pharmaceuticals (LXRX.US) was first covered by Leerink Partners, which gave it an superior market rating and a target price of $5.00.
Lexicon Pharmaceuticals Analyst Ratings
Leerink Partners Starts Lexicon Pharmaceuticals With Outperform Rating, $5 Price Target
Lexicon Pharmaceuticals: A Buy Rating on Strong Market Prospects and Innovative Pipeline
Needham: Reiterates that Lexicon Pharmaceuticals (LXRX.US) holds the rating.
Lexicon Pharmaceuticals Analyst Ratings
Lexicon Pharmaceuticals Analyst Ratings
Needham: Reiterates that Lexicon Pharmaceuticals (LXRX.US) holds the rating.
Analysts Conflicted on These Healthcare Names: Xoma (XOMA) and Lexicon Pharmaceuticals (LXRX)
Piper Sandler Remains a Buy on Lexicon Pharmaceuticals (LXRX)
Analysts Are Bullish on Top Healthcare Stocks: Cooper Co (COO), Lexicon Pharmaceuticals (LXRX)
Piper Sandler Sticks to Its Buy Rating for Lexicon Pharmaceuticals (LXRX)
Lexicon Pharmaceuticals (LXRX) Receives a Buy From Piper Sandler
Citigroup Adjusts Price Target on Lexicon Pharmaceuticals to $8 From $6, Keeps Buy Rating
Analysis
Price Target
No Data
